Please login to the form below

Not currently logged in
Email:
Password:

Atlas Genetics appoints Jeffery Luber as CEO

Former CEO Dr John Clarkson will move into an executive chairman position

Atlas Genetics has appointed its new chief executive officer in the form of Jeffrey Luber, as he succeeds Dr John Clarkson who transitions into executive chairman.

Luber also joins the company’s board following experience in the life sciences industry and holding multiple leadership roles including CEO of EXACT Sciences.

He said: “I am thrilled to join Atlas Genetics given the power of its platform, the strength of its board and leadership team, and its experience investor syndicate.

“As diagnostic testing increasingly becomes more decentralised, I look forward to working with the team to make Atlas the leading global player in POC testing.”

Prior to his new role at Atlas, Luber most recently led the return to growth and sale of Good Start Genetics to Invitae Corp, producing strategic partnerships with Roche Diagnostics and Amazon.

Dr John Clarkson, founding CEO, Atlas Genetics, said: “Jeff’s proven track record and extensive experience in the commercialisation of in vitro diagnostics will be invaluable as we enter the next, exciting phase of growth aimed at improving the diagnosis and treatment of conditions affecting women and families.”

11th October 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics